Coronary Artery Bypass Surgery, Coronary Artery Disease, Neurological Injury, Off-Pump Coronary Artery Bypass, Postoperative Cognitive Dysfunction, Postoperative Delirium, Stroke
Conditions
Keywords
Brain Injuries, Neurological Injury, Stroke, Postoperative Cognitive Dysfunction, Postoperative Delirium, Coronary Artery Disease, Coronary Artery Bypass Grafting, Coronary Artery Bypass Surgery, Bypass surgery, Beating Heart Coronary Artery Bypass, Off-Pump Coronary Artery Bypass
Brief summary
The objective of this study is to investigate the value of employing the aortic no-touch off-pump coronary artery bypass technique and the practice of carbon dioxide surgical field flooding for the prevention of type 1 and 2 neurological injuries following surgical coronary revascularization.
Detailed description
Neurological injuries remain a major concern following coronary artery bypass grafting (CABG) that offset survival benefit of CABG over percutaneous coronary interventions. Among numerous efforts to combat this issue, is off-pump CABG (OPCABG) that obviates the need for extracorporeal circulation and is associated with improved outcomes. The objective of this study is to examine whether the neuroprotective effect of OPCABG can be further pronounced by the use of two state-of-the-art operating techniques. In this randomised, controlled, investigator and patient blinded single center superiority trial with three parallel arms a total of 360 patients will be recruited. They will be allocated in a 1:1:1 ratio to two treatment and one control arms. Treatment arms undergoing either aortic no-touch OPCABG or OPCABG with a partial clamp applying carbon dioxide surgical field flooding will be compared against control arm undergoing OPCABG. The primary endpoint will be the appearance of new lesions on control brain magnetic resonance imaging 3 days after surgery. Secondary endpoints will include the prevalence of new focal neurological deficits in the first 7 days after surgery, the occurrence of postoperative cognitive dysfunction at either 1 week or 3 months after surgery and the incidence of delirium in the first 7 days after surgery. Data will be analysed on intention-to-treat principles and a per protocol basis.
Interventions
PROCEDUREaortic no-touch OPCABG
(Study arm 1) In this intervention only the internal mammary artery grafts will be used (i.e. left internal mammary artery graft, right internal mammary artery graft, or a Y-graft that uses right internal mammary artery graft anastomosed onto left internal mammary artery graft to allow for a wide territory of myocardial revascularization). However, in the rare event that the aforementioned approach is insufficient to reach all target vessels, a reversed (great) saphenous vein graft may be used to extend the left internal mammary artery graft or the right internal mammary artery graft.
PROCEDUREOPCABG with partial clamp applying carbon dioxide
(Study arm 2) In this intervention chest cavity will be insufflated with carbon dioxide at a flow above 5 l/min during the entire surgical procedure.
PROCEDUREOPCABG with partial clamp
(Study arm 3) This is the control arm undergoing traditional OPCABG with partial clamp.
Sponsors
Collegium Medicum w Bydgoszczy
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Intervention model description
The CANON trial is designed as a randomised, controlled, investigator and patient blinded single center superiority trial with three parallel arms and a primary endpoint being the appearance of new lesions on control brain magnetic resonance imaging 3 days after surgery.
Eligibility
Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* elective and/or urgent coronary artery bypass
Exclusion criteria
* emergent and salvage setting * score below age- and education-adjusted cut-off scores in mini mental state examination * score above 8 on the subscales of hospital anxiety and depression scale * neurologic deficit of any etiology * previous psychiatric illness * use of tranquilizers or antipsychotics * alcohol or drug abuse * history of cardiac surgery * left ventricular ejection fraction less than 30% * extracranial carotid artery stenosis of more than 70% * body mass index of more than 35 kg/m2 * any contraindication for magnetic resonance imaging (e.g., magnetic resonance imaging - incompatible implantable device and claustrophobia)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| New lesions on control brain magnetic resonance imaging. | 3 days after surgery | Appearance of new lesions on control brain magnetic resonance imaging 3 days after surgery. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| New focal neurological deficits. | 7 days after surgery | Prevalence of new focal neurological deficits in the first 7 days after surgery. |
| Occurence of postoperative cognitive dysfunction | 1 week or 3 months after surgery | Occurrence of postoperative cognitive dysfunction at either 1 week or 3 months after surgery |
| Incidence of delirium | 7 days after surgery | Incidence of delirium in the first 7 days after surgery. |
Countries
Poland
Outcome results
None listed